PT  - JOURNAL ARTICLE
AU  - Olshen, Adam B.
AU  - Garcia, Ariadna
AU  - Kapphahn, Kristopher I.
AU  - Weng, Yingjie
AU  - Wesson, Paul D.
AU  - Rutherford, George W.
AU  - Gonen, Mithat
AU  - Desai, Manisha
TI  - COVIDNearTerm: A Simple Method to Forecast COVID-19 Hospitalizations
AID  - 10.1101/2021.10.08.21264785
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.08.21264785
4099  - http://medrxiv.org/content/early/2021/10/09/2021.10.08.21264785.short
4100  - http://medrxiv.org/content/early/2021/10/09/2021.10.08.21264785.full
AB  - COVID-19 has caused tremendous death and suffering since it first emerged in 2019. In response, models were developed to help predict the course of various disease metrics, and these models have been relied upon to help guide public health policy. Here we present a method called COVIDNearTerm to “forecast” hospitalizations in the short term, two to four weeks from the time of prediction. COVIDNearTerm is based on an autoregressive model and utilizes a parametric bootstrap approach to make predictions. We evaluated COVIDNearTerm on San Francisco Bay Area hospitalizations and compared it to models from the California COVID Assessment Tool (CalCAT). We found that that COVIDNearTerm pre-dictions were more accurate than the CalCAT ensemble predictions for all comparisons and any CalCAT component for a majority of comparisons. For instance, at the county level our 14-day hospitalization median absolute percentage errors ranged from 16% to 36%. For those same comparisons the CalCAT ensemble errors were between 30% and 59%. COVIDNearT-erm is also easier to use than some other methods. It requires only previous hospitalization data and there is an open source R package that implements the algorithm.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by a Rise Grant from Stanford ChEM-H and NCI P30CA008748.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/olshena/COVIDNearTerm/Manuscript/reproduce.zip